- Press releases
- Country: United States
Novo to present new CagriSema and Wegovy® data at ObesityWeek® 2026, including data on treatment experience with Wegovy® pill in the real world
New data on Novo's investigational obesity treatment, CagriSema, explores changes in weight-related quality of life and the potential for weight loss at lower doses1,2 Wegovy® data includes new insights into real-world patient treatment experience in adults aged 65 and older, impact on...